Protogenix
Founded 2020 · $250K raised
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- proto-genix.com
- Total Funding
- $250K
- Last Round
- $250K SeedDec 2025
- Rounds
- 1
About
Protogenix (formerly Forte Protein) is an early-stage biotechnology company developing a novel protein production platform. The company is focused on making protein manufacturing faster and more cost-effective. The website is currently in a coming-soon state, limiting available detail.
Summary
Protogenix is a Biotech company, founded in 2020. It has raised $250K in total across 1 round, most recently a $250K Seed round in Dec 2025. Investors include IndieBio, SOSV and New York Ventures.
Tech & App Stack
6 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2025
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...